AnalystsMichael HigginsMichael Higgins's Stock Forecasts
AnalystsMichael Higgins
Analyst Ranking
Bottom 5%
#4694 out of 4929 analysts
Average Return
-26.01%
Win Rate
11%2 out of 18
Risk vs Reward
Poor
Good
Michael Higgins Analyst Color
Get additional color on Michael Higgins's coverage of popular stocks
Michael Higgins's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Forte Biosciences IncFBRX | 1 | Strong Buy | $68.75 | N/A | Upgrades | a year ago |
Marinus Pharmaceuticals IncMRNS | 1 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Ovid Therapeutics IncOVID | 1 | Strong Buy | $7.00 | N/A | Reiterates | 2 years ago |
Scynexis IncSCYX | 1 | Strong Buy | $15.00 | N/A | Reiterates | 2 years ago |
Artelo Biosciences IncARTL | 2 | Strong Buy | $360.00 | N/A | Reiterates | 2 years ago |
Viridian Therapeutics IncVRDN | 2 | Strong Buy | $40.00 | N/A | Reiterates | 2 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Reiterates | 2 years ago |
Biomx IncPHGE | 2 | Strong Buy | $80.00 | N/A | Maintains | 3 years ago |
4d Pharma PLCLBPS | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Novavax IncNVAX | 2 | Strong Sell | $105.00 | N/A | Downgrades | 5 years ago |
Zogenix IncZGNX | 1 | Hold | $35.00 | N/A | Downgrades | 5 years ago |
Virtu Financial IncVIRT | 2 | Strong Buy | $29.00 | N/A | Upgrades | 7 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 1 | Strong Buy | $1,050.00 | N/A | Initiates Coverage On | 8 years ago |
Cempra IncCEMP | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.